Related Experiment Video

Updated: Jul 15, 2026

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method
08:15

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

Hypertension and the kidney

J M Krzesinski1, E P Cohen

  • 1Division of Nephrology/Transplantation, University of Liège, Sart Titman B35, Belgium. jm.krzesinski@chu.ulg.ac.be

Acta Clinica Belgica
|April 25, 2007
PubMed

Insights

Essential hypertension and kidney disease are closely linked, with high blood pressure accelerating kidney failure. Aggressive blood pressure management is crucial for patients with chronic kidney disease, especially using renin-angiotensin axis blockers.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • The kidney can be a cause of essential hypertension, leading to renal disease.
  • Hypertension is prevalent in chronic kidney disease (CKD) and accelerates kidney failure.
  • A strong link exists between hypertension and kidney health.

Purpose of the Study:

  • To emphasize the critical link between hypertension and kidney disease.
  • To advocate for aggressive blood pressure control in CKD patients.
  • To highlight the benefits of specific antihypertensive drug classes.

Main Methods:

  • Review of existing literature on hypertension and kidney disease.
  • Analysis of blood pressure goals in CKD patients.
  • Evaluation of antihypertensive drug classes, focusing on renin-angiotensin axis blockers.

Main Results:

  • Hypertension is a significant risk factor for CKD progression.
  • Recommended blood pressure goal for CKD patients is <130/80 mmHg, or <125/75 mmHg with proteinuria >1g/day.
  • Renin-angiotensin axis blockers provide nephroprotective and cardioprotective benefits beyond blood pressure reduction.

Conclusions:

  • Aggressive hypertension management is vital for CKD patients.
  • Specific blood pressure targets should be individualized based on proteinuria.
  • Renin-angiotensin axis blockers are recommended for their dual protective effects.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...